
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.95 | $88.57 (0%) | 🛒 Add to cart |
| 60 | $2.53 | $177.15 $151.98 (14%) | 🛒 Add to cart |
| 90 | $2.39
Best per pill | $265.72 $215.40 (19%) | 🛒 Add to cart |
Synonyms | |||
Similar products

More info:
Tizanidine: Effective Muscle Spasticity Management - Evidence-Based Review
Tizanidine hydrochloride is a centrally acting alpha-2 adrenergic agonist primarily used as a skeletal muscle relaxant. This imidazoline derivative shares structural similarities with clonidine but possesses significantly greater myospasticity reduction properties with less potent antihypertensive effects. Available in both immediate-release (2mg, 4mg) and extended-release (2mg, 4mg, 6mg) formulations, tizanidine represents a cornerstone in spasticity management across multiple neurological conditions. The medication’s unique receptor binding profile enables targeted spasticity control while minimizing cardiovascular side effects compared to older muscle relaxants.
baclofen
Baclofen represents one of those fascinating pharmaceutical agents that somehow manages to bridge multiple therapeutic domains while maintaining a remarkably specific mechanism. Initially developed as an antispasticity agent, this GABA-B receptor agonist has demonstrated utility far beyond its original indications. We’ve been working with this molecule since the late 1980s, and I still find myself surprised by its nuances. The chemical structure—β-(4-chlorophenyl)-GABA—belongs to the arylalkylamine family, but what truly matters clinically is its selective action on GABA-B receptors in the spinal cord and brain.
ciplox
Ciprofloxacin, commonly encountered in clinical practice as Ciplox, represents a cornerstone fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Its development marked a significant advancement in antimicrobial therapy, particularly for complex infections where other classes had begun to show limitations. In my two decades of infectious disease work, I’ve seen its role evolve from a first-line agent to a more targeted one, a shift driven by both its potent efficacy and the sobering reality of antimicrobial stewardship.
Cipro: Potent Antibacterial Therapy for Bacterial Infections - Evidence-Based Review
Ciprofloxacin, commonly referred to as Cipro, is a broad-spectrum fluoroquinolone antibiotic with potent bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens. It’s been a workhorse in clinical practice for decades, particularly for complicated urinary tract infections, respiratory infections, and gastrointestinal infections caused by susceptible organisms. The development of bacterial resistance to older antibiotics created an urgent need for agents like Cipro, which targets bacterial DNA gyrase and topoisomerase IV—enzymes critical for DNA replication.
Clonidine: Multimodal Therapeutic Agent for Hypertension and Beyond - Evidence-Based Review
Clonidine is a centrally acting alpha-2 adrenergic agonist that’s been in clinical use for decades, originally developed as a nasal decongestant before its potent antihypertensive properties were discovered. It’s fascinating how this medication has found applications far beyond blood pressure control - we’re now using it for ADHD, opioid withdrawal, menopausal hot flashes, and even perioperative settings. The versatility stems from its unique mechanism of action that modulates sympathetic outflow from the brainstem.
flexeril
Cyclobenzaprine hydrochloride - a centrally-acting skeletal muscle relaxant that’s been in our toolkit since the 1970s, though we rarely stop to appreciate its unique pharmacology. Unlike other muscle relaxants that work peripherally, flexeril operates primarily at the brainstem level, reducing somatic motor activity through central nervous system depression without directly affecting skeletal muscle fibers or the neuromuscular junction. What’s fascinating is how it specifically depresses polysynaptic reflex pathways while leaving monosynaptic pathways relatively intact - this selectivity explains why it’s particularly effective for acute musculoskeletal conditions without causing complete muscle paralysis.
lioresal
Baclofen, marketed under the brand name Lioresal among others, is a medication primarily used to treat spasticity. It is a central nervous system (CNS) depressant and a GABA agonist, specifically a GABA-B receptor agonist. This means it works by mimicking the action of gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in your brain and spinal cord. By binding to GABA-B receptors, Lioresal (baclofen) reduces the excitability of nerve cells, leading to muscle relaxation and a decrease in spasticity.
Luvox: Effective Symptom Control for OCD and Anxiety Disorders - Evidence-Based Review
Fluvoxamine, commonly known by its brand name Luvox, is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication approved for the treatment of obsessive-compulsive disorder (OCD) and various anxiety disorders. It functions by increasing serotonin levels in the brain, which helps regulate mood, anxiety, and obsessive thoughts. Unlike many dietary supplements, Luvox is a prescription medication with a well-established role in clinical psychiatry, backed by decades of research and real-world application.
movfor
Product Description Movfor represents one of those rare clinical tools that actually delivers on its theoretical promise - a comprehensive mobility restoration system combining targeted neuromuscular stimulation with proprioceptive retraining. We’ve been using the third-generation devices in our rehabilitation center since 2021, and the results have consistently surprised even our most skeptical physiatrists. 1. Introduction: What is Movfor? Its Role in Modern Medicine Movfor stands for “Motor Function Optimizer and Restorer” - a Class II medical device that’s fundamentally changing how we approach neurorehabilitation and musculoskeletal recovery.
